Saving Tabby; C35 Expression as a Cancer Marker?; Interdisciplinary Research

Front Page Saving Tabby; C35 Expression as a Cancer Marker?; Interdisciplinary Research Saving Tabby Reprinted with permission from Nature © online April 7, 2003 Researchers in Switzerland reversed a genetic developmental defect in mice by injecting their pregnant mothers with a recombinant protein. These smaller-than-normal patients, so-called Tabby mice, lack specialized hairs, teeth, and sweat glands. Both Tabby and its human counterpart of this disease, an X-linked form

Written byBrendan Maher
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

Saving Tabby

Researchers in Switzerland reversed a genetic developmental defect in mice by injecting their pregnant mothers with a recombinant protein. These smaller-than-normal patients, so-called Tabby mice, lack specialized hairs, teeth, and sweat glands. Both Tabby and its human counterpart of this disease, an X-linked form of ectodermal dysplasia, result from a mutated gene that is highly conserved in mouse and man, ectodysplasin A, or EDA.

Pascal Schneider and colleagues at the University of Lausanne created a friendly Trojan horse of sorts by fusing a correct version of the EDA receptor-binding domain to the C-terminus of immunoglobulin G1's Fc domain. The Fc fusion ensures delivery through placental protein receptors as mother mouse passes immune protection on to her developing pups. The EDA enters the fetal systems to aid development. The treatment resulted in larger mice that had more specialized hair types, better tooth development, and sweat glands (O. Gaide et ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies